CREDIT AGREEMENT dated as of September 9, 2011 among VIROPHARMA INCORPORATED, as Borrower The Lenders Party Hereto JPMORGAN CHASE BANK, N.A. as Administrative Agent and BMO HARRIS FINANCING INC., TD BANK, N.A. and MORGAN STANLEY BANK, N.A. as...Credit Agreement • October 27th, 2011 • Viropharma Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 27th, 2011 Company Industry JurisdictionCREDIT AGREEMENT (this “Agreement”) dated as of September 9, 2011 among VIROPHARMA INCORPORATED, the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent and BMO HARRIS FINANCING INC., TD BANK, N.A. and MORGAN STANLEY BANK, N.A.,, as Co-Syndication Agents.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 27th, 2011 • Viropharma Inc • Pharmaceutical preparations • New York
Contract Type FiledOctober 27th, 2011 Company Industry JurisdictionThis Exclusive License Agreement (this “Agreement”) is made and entered into effective as of September 29, 2011 (the “Effective Date”) between, on the one hand, Intellect Neurosciences, Inc., a corporation organized under the laws of Delaware (“Intellect Neurosciences”) and Intellect USA, Inc., a corporation organized under the laws of Delaware (“Intellect USA” and, collectively with Intellect Neurosciences, “INS”), and, on the other hand, ViroPharma Incorporated, a corporation organized under the laws of Delaware (“ViroPharma”). INS and ViroPharma are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”